Serum lactate dehydrogenase (LDH) as a prognostic selection criterion for ipilimumab treatment in metastatic melanoma

Author(s):
Blank, C.U.; Kelderman, S.; Tinteren, H. van; Heemskerk, B.; Brom, R. van den; Hospers, G.A.; Eertwegh, A.J.M. van den; Kapiteijn, E.; Groot, J.W. de; Jansen, R.L.; Fiets, W.E.; Krzystanek, M.; Szallasi, Z.; Furness, A.J.S.; Renn, A.; Gore, M.E.; Lorigan, P.; Schumacher, T.; Haanen, J.B.A.G.; Larkin, J.M.G.
Published
2013
Publication type
Article / Letter to editor
Date issued
2013-05-20
Language
English
Is part of
Journal of Clinical Oncology (2013), No. 15
hdl
1887/104677